LEADER 00944nam0-2200337---450- 001 990009650650403321 005 20121128111852.0 010 $a90-201-1032-2 035 $a000965065 035 $aFED01000965065 035 $a(Aleph)000965065FED01 035 $a000965065 100 $a20121128d1978----km-y0itay50------ba 101 0 $aeng 105 $aa-------001yy 200 1 $aInterior lighting$fJ. B. de Boer, D. Fischer 210 $aDeventer, Hollande$cKluwer Technische Boeken$d1978 215 $a336 p.$cill.$d24 cm 225 1 $aPhilips technical library 610 0 $aIlluminazione interna 610 0 $aIlluminotecnica 676 $a621.322 700 1$aBoer,$bJ. B. : de$0282519 701 1$aFischer,$bD.$0518288 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009650650403321 952 $a10 D IV 79$bDonoDIEL$fDINEL 959 $aDINEL 996 $aInterior lighting$9840062 997 $aUNINA LEADER 03744nam 2200649Ia 450 001 9910781187903321 005 20230721005829.0 010 $a0-309-14874-X 010 $a1-282-45484-6 010 $a9786612454844 010 $a0-309-13045-X 035 $a(CKB)2550000000010224 035 $a(EBL)3378570 035 $a(SSID)ssj0000410972 035 $a(PQKBManifestationID)11293010 035 $a(PQKBTitleCode)TC0000410972 035 $a(PQKBWorkID)10351764 035 $a(PQKB)10755782 035 $a(MiAaPQ)EBC3378570 035 $a(Au-PeEL)EBL3378570 035 $a(CaPaEBR)ebr10364020 035 $a(CaONFJC)MIL245484 035 $a(OCoLC)923280829 035 $a(EXLCZ)992550000000010224 100 $a20090930d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAddressing the threat of drug-resistant tuberculosis$b[electronic resource] $ea realistic assessment of the challenge : workshop summary /$fRobert Giffin and Sally Robinson, rapporteurs; Institute of Medicine of the National Academies 210 $aWashington, D.C. $cNational Academies Press$d2009 215 $a1 online resource (253 p.) 300 $a"The Institute of Medicine's (IOM's) Forum on Drug Discovery, Development, and Translation held a workshop in Washington, DC, on November 5, 2008"--p. 2. 311 $a0-309-13044-1 320 $aIncludes bibliographical references. 327 $aReviewers -- Contents -- Tables, Figures, and Boxes -- Acronyms -- Summary -- Chapter 1. Introduction -- Chapter 2. The Global Spread of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis -- Chapter 3. MDR TB Transmission, HIV Coinfection, and Transmission Control -- Chapter 4. Diagnosis -- Chapter 6. Infrastructure and Health Care Delivery Systems -- 6 Global Systems for the Purchase and Delivery of TB Drugs -- Chapter 7. Research on the Global Control of TB: Understanding the Role of Drugs, Vaccines, and Funding -- Chapter 8. Strategies for Confronting the Global MDR and XDR TB Crisis -- References. -- Appendix A: Agenda -- Appendix B: Participant Biographies -- Appendix C: Partners In Health White Paper' stemming the Tide of Multidrug-Resistant Tuberculosis: Major Barriers to Addressing the Growing Epidemic -- 330 $a"Tuberculosis is one of the leading causes of death in the world today, with 4,500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is resistant to multiple drugs--a major and growing threat worldwide. The Institute of Medicine's Forum on Drug Discovery, Development, and Translation hosted a workshop on November 5, 2008, to address the mounting concern of drug-resistant TB. The session brought together a wide range of international experts to discuss what is known and not known about this growing threat, and to explore possible solutions."--Publisher's website. 606 $aMultidrug-resistant tuberculosis$vCongresses 606 $aTuberculosis$vCongresses 606 $aDrug resistance$vCongresses 606 $aAntitubercular agents$vCongresses 615 0$aMultidrug-resistant tuberculosis 615 0$aTuberculosis 615 0$aDrug resistance 615 0$aAntitubercular agents 676 $a616.9 701 $aGiffin$b Robert B$01510132 701 $aRobinson$b Sally$0620917 712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910781187903321 996 $aAddressing the threat of drug-resistant tuberculosis$93742454 997 $aUNINA